JPWO2022080249A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022080249A5
JPWO2022080249A5 JP2022556908A JP2022556908A JPWO2022080249A5 JP WO2022080249 A5 JPWO2022080249 A5 JP WO2022080249A5 JP 2022556908 A JP2022556908 A JP 2022556908A JP 2022556908 A JP2022556908 A JP 2022556908A JP WO2022080249 A5 JPWO2022080249 A5 JP WO2022080249A5
Authority
JP
Japan
Prior art keywords
serine
agent
preventive
inflammatory bowel
bowel disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022556908A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022080249A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/037311 external-priority patent/WO2022080249A1/ja
Publication of JPWO2022080249A1 publication Critical patent/JPWO2022080249A1/ja
Publication of JPWO2022080249A5 publication Critical patent/JPWO2022080249A5/ja
Pending legal-status Critical Current

Links

JP2022556908A 2020-10-12 2021-10-08 Pending JPWO2022080249A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020171646 2020-10-12
PCT/JP2021/037311 WO2022080249A1 (ja) 2020-10-12 2021-10-08 炎症性腸疾患の予防又は改善剤

Publications (2)

Publication Number Publication Date
JPWO2022080249A1 JPWO2022080249A1 (https=) 2022-04-21
JPWO2022080249A5 true JPWO2022080249A5 (https=) 2024-10-30

Family

ID=81208102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556908A Pending JPWO2022080249A1 (https=) 2020-10-12 2021-10-08

Country Status (2)

Country Link
JP (1) JPWO2022080249A1 (https=)
WO (1) WO2022080249A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4378088B2 (ja) * 2002-02-22 2009-12-02 日本臓器製薬株式会社 ピペラジン誘導体
US20100184708A1 (en) * 2007-09-11 2010-07-22 Dorian Bevec Use of gly-pro-glu-oh (gpe) as a therapeutic agent
JP2012214451A (ja) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd 炎症性疾患用アミノ酸組成物
US20210283082A1 (en) * 2018-06-07 2021-09-16 National University Corporation Kanazawa University Pharmaceutical composition for prevention or treatment of kidney damage
JP7467138B2 (ja) * 2020-01-30 2024-04-15 株式会社 資生堂 腸管バリア改善剤
US20230063703A1 (en) * 2020-02-18 2023-03-02 Keio University Drug and food for treating and/or preventing enteritis and/or hepatitis

Similar Documents

Publication Publication Date Title
CN1142783C (zh) 用于治疗高危葡萄糖耐量降低的药剂
JP5672264B2 (ja) 抗ヒトTNF−α抗体活性低下抑制剤
JP2005514441A5 (https=)
KR20160093000A (ko) 창자 과투과성을 치료하기 위한 티로신 하이드록실라제 억제제
JP2023109947A5 (https=)
WO2018193648A1 (ja) アルカリ性化剤による血液浄化
CA3127926A1 (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
CN112135625A (zh) 一种预防或治疗covid-19新冠肺炎的药物、食物及其应用
JPWO2022080249A5 (https=)
CN110799214A (zh) 利用碱化剂的血液净化
JP6119969B2 (ja) 血圧降下用アミノ酸含有組成物
AU2013362755A1 (en) Uses and methods for the treatment of liver diseases or conditions
CN1149988C (zh) 肝病治疗药
JP2019529572A5 (https=)
CN1127336C (zh) 肺性心病治疗剂
US8609160B2 (en) Composition and method of treating lipid encapsulated virus infections
CN1173698C (zh) 包含包衣的雷尼替丁、碱式柠檬酸铋和硫糖铝的对胃肠障碍具有治疗作用的可口服给药的药物制剂
JP6100510B2 (ja) 抗感冒剤
CA2709119C (en) Preventive or therapeutic agent for inflammatory bowel diseases
JP2021024835A (ja) 小腸潰瘍改善剤
WO1997044031A1 (en) Agent for treating allergic dermatitis
JP6465592B2 (ja) 涙液分泌促進組成物
WO2025026423A1 (en) Compositions, their use and manufacture for treatment of gastrointestinal conditions
JPH11171763A (ja) 肝疾患治療剤
KR100793236B1 (ko) 대장염 치료용 약학적 조성물